Cite
MLA Citation
Fatih Uckun et al.. “ATIM-06. TREATMENT OF RECURRENT/REFRACTORY (R/R) ANAPLASTIC ASTROCYTOMA (AA, WHO GRADE 3) PATIENTS WITH ANTI-TGFß2 RNA THERAPEUTIC OT-101 VERSUS TEMOZOLOMIDE IS ASSOCIATED WITH IMPROVED OVERALL SURVIVAL.” Neuro-oncology, vol. 21, n.d., p. vi2. http://access.bl.uk/ark:/81055/vdc_100101669180.0x000040